Letters to the Editor Published on December 11, 2025
As nursing homes across Pennsylvania continue to provide essential services to vulnerable populations, a looming policy change threatens to undermine the system that supports these facilities. At the core of long-term care (LTC) in the southeastern region of the commonwealth is a network of LTC pharmacies, which play a vital role in ensuring that seniors receive the medications they need. However, a transformative policy, set to take effect on January 1, could potentially cripple these pharmacies unless immediate action is taken by federal authorities.
The Inflation Reduction Act, passed during the Biden administration, introduced provisions that enable the federal government to negotiate prices for select brand-name drugs available to Medicare Part D beneficiaries. The intent behind this policy is to alleviate the financial burden on seniors, making essential medications more affordable. Nevertheless, this initiative is poised to have detrimental consequences for LTC pharmacies, which are already facing financial pressures.
By instituting “maximum fair prices” for specific medications, the reimbursement rates that LTC pharmacies receive will be significantly diminished. This reduction could lead to the financial instability of these pharmacies, putting at risk the services they provide to over 200,000 Medicare Part D beneficiaries aged 65 and older in need of long-term care. Such an outcome would not only jeopardize the health and safety of seniors who rely on these medications but could also disrupt the overall functioning of nursing homes and senior living facilities across the state.
To avert this crisis, the Trump administration has the option to enact an executive order to delay or modify the drug pricing policy until a viable payment model can be established. Additionally, there is an urgent need for Congress to pass the bipartisan Preserving Patient Access to Long-Term Care Pharmacies Act (HR 5031). If enacted, this legislation would introduce a temporary supply fee of for each prescription filled under the newly negotiated prices, a modest measure that could sustain pharmacies through 2027.
The implications of these policy decisions cannot be overlooked. For the welfare of Pennsylvania’s seniors, decisive action is required to ensure that the LTC pharmacy network remains intact and capable of serving those who depend on it for their health and well-being. It is paramount that policymakers prioritize an approach that safeguards the care infrastructure for our aging population, rather than allowing well-intentioned policies to precipitate a crisis in essential healthcare services. The future of senior care and the health of countless individuals may very well depend on the decisions made in the coming months.
As the deadline approaches, stakeholders must advocate for measures that will protect these critical pharmacies and maintain access to necessary medications for all seniors.
